Ignite Creation Date:
2025-12-25 @ 3:37 AM
Ignite Modification Date:
2025-12-26 @ 2:21 AM
Study NCT ID:
NCT00774202
Status:
COMPLETED
Last Update Posted:
2019-01-09
First Post:
2008-10-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP
Sponsor:
Weill Medical College of Cornell University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-11
Start Date Type:
None
Primary Completion Date:
2008-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-02
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-15
First Submit QC Date:
None
Study First Post Date:
2008-10-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-28
Results First Submit QC Date:
None
Results First Post Date:
2018-11-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-21
Last Update Post Date:
2019-01-09
Last Update Post Date Type:
ACTUAL